ESR1 and breast carcinoma: Other clinical studies also showed AR expression is higher (n = 573, 85%) among all breast cancer, however, multivariable analysis for short-term follow-up indicated higher metastasis among patients with AR+ER- tumors (HR 3.5; 95% CI 1.4-9.1) than other (AR and ER combinations).